Odyssey Thera's Unattributed VC - II Round

Odyssey Thera raised a round of funding on September 14, 2006. Investors include Pfizer Venture Investments.

Odyssey Thera offers technology that measures disease-relevant pathway activity within living human cells. Rapid identification of on-target and off-pathway activities of lead compounds enables select…

Articles about Odyssey Thera's Unattributed VC - II Round: